Bionow are delighted to announce PharmaKrysto as the winner of the 2017 BioCap Company Pitching Competition. PharmaKrysto’s goal is to prevent children and adults from experiencing pain, surgery and kidney failure as a result of cystinuria. This is a rare genetic condition that causes frequent kidney stone formation. They aim to develop a new, oral medication. PharmaKrysto has in-licenced innovative, patented, stone-disrupting molecules and will make this available to patients through regulatory approval. This family of novel molecules has shown its ability to stop crystal stones in animal models of cystinuria. PharmaKrysto is actively seeking funding partners and any anyone interested in learning more can contact the team at info@pharmakrysto.com. Head judge Gareth King from Catapult Ventures said “I am extremely grateful to my fellow judges Simon Graindorge from IP Group, Ashish Patel from Mercia, Claire Brown from BioCity and Mark Warne from Enterprise Ventures. We found the quality of all the pitches to be extremely high and found it difficult to select a winner but the PharmaKrysto application just edged it.”The BioCap Company Pitching Competition is a fantastic opportunity for companies who are seeking investment, to present to the international life science investment community, more than 60 of whom were present at the event. The event is organised by Bionow in partnership with RSM, Appleyard Lees and Slater Heelis and is sponsored by Catapult Ventures and Manchester Science Partnerships. In total nearly 200 delegates attended the event making this the largest and only gathering focused on life science investment in the North of England. The event has been running for 5 years and has successfully brought together international investors and companies resulting in greater funding into companies in the North of England. Geoff Davison, CEO of Bionow said “We are delighted in the quality of the pitching applications received and congratulate PharmaKrysto. BioCap was conceived 6 years ago to increase the visibility of the fantastic life sciences opportunities in the North and the numbers and quality of investors now attending the event show the quality and breadth of opportunities in the North of England and means that all the hard work has been worth it.” The 10 competition finalists who pitched at the conference were:- · Elbe Valley Medical · Filisia Interfaces · GlySK · HolistX · GlySK · iQur · NeuDrive Ltd · Ockham BioTech · PharmaKrysto About Bionow Bionow is the life-sciences membership organisation for the North of England and supports business growth, competitiveness and innovation within the biomedical and life science sectors. Bionow’s membership offering focuses upon the specific needs of firms at their different stages of development, including dedicated business support programmes, shared procurement schemes with significant cost savings, exclusive insurance benefits, recruitment and training services, local and national events and access to a vibrant network of businesses. www.bionow.co.uk Contact: Helen Williams, Event & Marketing Manager helen.williams@bionow.co.uk 07714 168 0202
Original Article: 2017 BioCap Pitching Competition Winner Announced